Proteins


  •  
  •  
  •  
  •  

  •  
  •  
  •  

  •  
  •  
  •  
  •  
  •  
  •  
  •  

Proteins

Alpha Synuclein

Human, recombinant
Full length, UniProtKB accession P37840
MW = 14.4 kDa
CAT # G08SY002

Calbindin D9K

Bovine, recombinant
residues 5-79, P47M mutant, UniProtKB accession P02633
MW = 8.5 kDa
CAT # G02CLB01

Calmodulin

Human, recombinant
Full length, UniProtKB accession P62158
MW = 16.6 kDa
CAT # G02CLM01

Calmodulin N60D

Human, recombinant, N60D mutant
Full length, UniProtKB accession P62158
MW = 16.6 kDa
CAT # G02CLM60

GB1

GB1

Recombinant, from Streptococcus sp
Residues 303-357, T303Q mutant, UniProtKB accession P19909
MW = 6.2 kDa
CAT # G03GB101

MBP - Maltose Binding Protein

Recombinant protein from E. coli
Residues 27-392, T28I mutant, UniProtKB accession P0AEX9
MW = 40.3 kDa
CAT # G03MBP01

MMP1 - catalytic domain

Human, recombinant
Residues 106-261, UniProtKB accession P03956
MW = 17.6 kDa
EC # 3.4.24.7
CAT # G04MP01C

MMP1 - hemopexin like domain

Human, recombinant.
residues 274-469, swissprot accession P03956
MW = 23.4 kDa.
EC # 3.4.24.7
CAT # G04MP01H

MMP10 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 99-263, F170N mutant, UniProtKB accession P09238
MW = 18.6 kDa
EC # 3.4.24.24
CAT # G04MP10Cm

MMP12 - catalytic domain

Human, recombinant
Residues 106-263, UniProtKB accession P39900
MW = 17.6 kDa
EC # 3.4.24.65
CAT # G04MP12C

MMP12 - catalytic domain, inactive mutant

Human, recombinant
Residues 106-263, UniProtKB accession P39900
MW = 17.6 kDa
EC # 3.4.24.65
CAT # G04MP12Ci

MMP12 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 106-263, UniProtKB accession P39900
MW = 17.6 kDa
EC # 3.4.24.65
CAT # G04MP12Cm

MMP12 - hemopexin like domain

Human, recombinant
Residues 278-470, UniProtKB accession P39900
MW = 23.2 kDa
EC # 3.4.24.7
CAT # G04MP12H

MMP13 - catalytic domain, inactive mutant, fibronectin deficient

Human, recombinant.
Residues 104-268, F175D mutant, UniProtKB accession P45452
MW = 18.6 kDa.
EC # 3.4.24.24
CAT # G04MP13Ci

MMP13 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 104-268, F175D mutant, UniProtKB accession P45452
MW = 18.6 kDa
EC # 3.4.24.24
CAT # G04MP13Cm

MMP14 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 114-290, C127S mutant, UniProtKB accession P50281
MW = 20.1 kDa.
EC # 3.4.24.80
CAT # G04MP14Cm

MMP19 - catalytic domain

Human, recombinant
Residues 101-256, UniProtKB accession Q99542
MW = 17.6 kDa
EC # 3.4.24.-
CAT # G04MP19C

MMP2 - catalytic domain fibronectin deficient

Human, recombinant
Residues 115-214 and 393-447 (residues numbers are based on the unprocessed precursor), UniProtKB accession P08253
MW = 17.9 kDa
EC # 3.4.24.24
CAT # G04MP02C

MMP2 - hemopexin like domain

Human, recombinant
Residues 467-660, UniProtKB accession P08253
MW = 22.4 kDa
EC # 3.4.24.24
CAT # G04MP02H

MMP20 - catalytic domain

Human, recombinant
Residues 113-271, UniProtKB accession O60882
MW = 17.5 kDa
EC # 3.4.24.-
CAT # G04MP20C

123>

Proteins

Alpha Synuclein

Human, recombinant
Full length, UniProtKB accession P37840
MW = 14.4 kDa
CAT # G08SY002

Calbindin D9K

Bovine, recombinant
residues 5-79, P47M mutant, UniProtKB accession P02633
MW = 8.5 kDa
CAT # G02CLB01

Calmodulin

Human, recombinant
Full length, UniProtKB accession P62158
MW = 16.6 kDa
CAT # G02CLM01

Calmodulin N60D

Human, recombinant, N60D mutant
Full length, UniProtKB accession P62158
MW = 16.6 kDa
CAT # G02CLM60

GB1

GB1

Recombinant, from Streptococcus sp
Residues 303-357, T303Q mutant, UniProtKB accession P19909
MW = 6.2 kDa
CAT # G03GB101

MBP - Maltose Binding Protein

Recombinant protein from E. coli
Residues 27-392, T28I mutant, UniProtKB accession P0AEX9
MW = 40.3 kDa
CAT # G03MBP01

MMP1 - catalytic domain

Human, recombinant
Residues 106-261, UniProtKB accession P03956
MW = 17.6 kDa
EC # 3.4.24.7
CAT # G04MP01C

MMP1 - hemopexin like domain

Human, recombinant.
residues 274-469, swissprot accession P03956
MW = 23.4 kDa.
EC # 3.4.24.7
CAT # G04MP01H

MMP10 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 99-263, F170N mutant, UniProtKB accession P09238
MW = 18.6 kDa
EC # 3.4.24.24
CAT # G04MP10Cm

MMP12 - catalytic domain

Human, recombinant
Residues 106-263, UniProtKB accession P39900
MW = 17.6 kDa
EC # 3.4.24.65
CAT # G04MP12C

MMP12 - catalytic domain, inactive mutant

Human, recombinant
Residues 106-263, UniProtKB accession P39900
MW = 17.6 kDa
EC # 3.4.24.65
CAT # G04MP12Ci

MMP12 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 106-263, UniProtKB accession P39900
MW = 17.6 kDa
EC # 3.4.24.65
CAT # G04MP12Cm

MMP12 - hemopexin like domain

Human, recombinant
Residues 278-470, UniProtKB accession P39900
MW = 23.2 kDa
EC # 3.4.24.7
CAT # G04MP12H

MMP13 - catalytic domain, inactive mutant, fibronectin deficient

Human, recombinant.
Residues 104-268, F175D mutant, UniProtKB accession P45452
MW = 18.6 kDa.
EC # 3.4.24.24
CAT # G04MP13Ci

MMP13 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 104-268, F175D mutant, UniProtKB accession P45452
MW = 18.6 kDa
EC # 3.4.24.24
CAT # G04MP13Cm

MMP14 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 114-290, C127S mutant, UniProtKB accession P50281
MW = 20.1 kDa.
EC # 3.4.24.80
CAT # G04MP14Cm

MMP19 - catalytic domain

Human, recombinant
Residues 101-256, UniProtKB accession Q99542
MW = 17.6 kDa
EC # 3.4.24.-
CAT # G04MP19C

MMP2 - catalytic domain fibronectin deficient

Human, recombinant
Residues 115-214 and 393-447 (residues numbers are based on the unprocessed precursor), UniProtKB accession P08253
MW = 17.9 kDa
EC # 3.4.24.24
CAT # G04MP02C

MMP2 - hemopexin like domain

Human, recombinant
Residues 467-660, UniProtKB accession P08253
MW = 22.4 kDa
EC # 3.4.24.24
CAT # G04MP02H

MMP20 - catalytic domain

Human, recombinant
Residues 113-271, UniProtKB accession O60882
MW = 17.5 kDa
EC # 3.4.24.-
CAT # G04MP20C

123>

Proteins

Alpha Synuclein

Human, recombinant
Full length, UniProtKB accession P37840
MW = 14.4 kDa
CAT # G08SY002

Calbindin D9K

Bovine, recombinant
residues 5-79, P47M mutant, UniProtKB accession P02633
MW = 8.5 kDa
CAT # G02CLB01

Calmodulin

Human, recombinant
Full length, UniProtKB accession P62158
MW = 16.6 kDa
CAT # G02CLM01

Calmodulin N60D

Human, recombinant, N60D mutant
Full length, UniProtKB accession P62158
MW = 16.6 kDa
CAT # G02CLM60

GB1

GB1

Recombinant, from Streptococcus sp
Residues 303-357, T303Q mutant, UniProtKB accession P19909
MW = 6.2 kDa
CAT # G03GB101

MBP - Maltose Binding Protein

Recombinant protein from E. coli
Residues 27-392, T28I mutant, UniProtKB accession P0AEX9
MW = 40.3 kDa
CAT # G03MBP01

MMP1 - catalytic domain

Human, recombinant
Residues 106-261, UniProtKB accession P03956
MW = 17.6 kDa
EC # 3.4.24.7
CAT # G04MP01C

MMP1 - hemopexin like domain

Human, recombinant.
residues 274-469, swissprot accession P03956
MW = 23.4 kDa.
EC # 3.4.24.7
CAT # G04MP01H

MMP10 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 99-263, F170N mutant, UniProtKB accession P09238
MW = 18.6 kDa
EC # 3.4.24.24
CAT # G04MP10Cm

MMP12 - catalytic domain

Human, recombinant
Residues 106-263, UniProtKB accession P39900
MW = 17.6 kDa
EC # 3.4.24.65
CAT # G04MP12C

MMP12 - catalytic domain, inactive mutant

Human, recombinant
Residues 106-263, UniProtKB accession P39900
MW = 17.6 kDa
EC # 3.4.24.65
CAT # G04MP12Ci

MMP12 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 106-263, UniProtKB accession P39900
MW = 17.6 kDa
EC # 3.4.24.65
CAT # G04MP12Cm

MMP12 - hemopexin like domain

Human, recombinant
Residues 278-470, UniProtKB accession P39900
MW = 23.2 kDa
EC # 3.4.24.7
CAT # G04MP12H

MMP13 - catalytic domain, inactive mutant, fibronectin deficient

Human, recombinant.
Residues 104-268, F175D mutant, UniProtKB accession P45452
MW = 18.6 kDa.
EC # 3.4.24.24
CAT # G04MP13Ci

MMP13 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 104-268, F175D mutant, UniProtKB accession P45452
MW = 18.6 kDa
EC # 3.4.24.24
CAT # G04MP13Cm

MMP14 - catalytic domain, mutant with improved stability

Human, recombinant
Residues 114-290, C127S mutant, UniProtKB accession P50281
MW = 20.1 kDa.
EC # 3.4.24.80
CAT # G04MP14Cm

MMP19 - catalytic domain

Human, recombinant
Residues 101-256, UniProtKB accession Q99542
MW = 17.6 kDa
EC # 3.4.24.-
CAT # G04MP19C

MMP2 - catalytic domain fibronectin deficient

Human, recombinant
Residues 115-214 and 393-447 (residues numbers are based on the unprocessed precursor), UniProtKB accession P08253
MW = 17.9 kDa
EC # 3.4.24.24
CAT # G04MP02C

MMP2 - hemopexin like domain

Human, recombinant
Residues 467-660, UniProtKB accession P08253
MW = 22.4 kDa
EC # 3.4.24.24
CAT # G04MP02H

MMP20 - catalytic domain

Human, recombinant
Residues 113-271, UniProtKB accession O60882
MW = 17.5 kDa
EC # 3.4.24.-
CAT # G04MP20C

123>

Via Madonna del Piano, 6
50019 Sesto Fiorentino (FI), Italy
Tel. +39 055 457 4258
Fax +39 055 457 4925
E-mail: info@giottobiotech.com
VAT number: IT06188160482

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close